奥浦迈:2024年境外收入占主营业务收入比例达30%以上,业务拓展主要以直销方式为主

Core Insights - The company has confirmed that its overseas revenue, particularly from the EU region, constitutes over 30% of its total operating income for 2024, as per the annual report [1] - The company's sales strategy primarily relies on direct sales, with no subsidiaries established in EU countries to date [1] Group 1 - The company is currently finalizing its financial data for 2025, indicating ongoing assessments of its revenue streams [1] - The company has not set up any subsidiaries in EU countries, focusing instead on direct sales to EU customers [1]

Shanghai OPM Biosciences -奥浦迈:2024年境外收入占主营业务收入比例达30%以上,业务拓展主要以直销方式为主 - Reportify